Biotech’s IPO tide is finally turning, thanks in part to the recent M&A surge
After years of suffering from a bear market and more than 14 months of geopolitical turmoil shaking the macroenvironment, biotech appears to be moving on.
Biotech’s IPO tide is finally turning, thanks in part to the recent M&A surge Read More »
